Galecto, Inc. (GLTO)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Hans T. Schambye
Employees:
40
GALECTO BIOTECH AB, OLE MAALOES VEJ3, COPENHAGEN, DENMARK DK-2200
45-70-70-52-10

Galecto, Inc. develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the. treatment of myelofibrosis. GB0139, an inhaled. inhibitor of galectin-3 that is in. Phase IIb clinical trials for severe fibrotic lung diseases.

Data derived from most recent annual or quarterly report
Market Cap 16.891 Million Shares Outstanding27.113 Million Avg 30-day Volume 180.333 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.3
Price to Revenue0.0 Debt to Equity0.0 EBITDA-47.098 Million
Price to Book Value0.5217 Operating Margin0.0 Enterprise Value-24.676 Million
Current Ratio3.748 EPS Growth0.266 Quick Ratio3.519
1 Yr BETA 1.9126 52-week High/Low 3.7 / 0.5 Profit Margin0.0
Operating Cash Flow Growth25.2023 Free Cash Flow to Firm (FCFF) TTM -29.121 Million Free Cash Flow to Equity (FCFE) TTM-32.772 Million
Altman Z-Score-8.3683
View SEC Filings from GLTO instead.

View recent insider trading info

Galecto, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding GLTO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GLTO

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-04-17 by ORBIMED ADVISORS LLC
  • 4: filed on 2023-04-12 by ORBIMED ADVISORS LLC
  • 4: filed on 2023-04-07 by ORBIMED ADVISORS LLC
  • 4: filed on 2023-01-05 by OESTREICH STEPHANIE
  • 4: filed on 2023-01-05 by FREVE JONATHAN
  • 4: filed on 2023-01-05 by WINSLOW GARRETT
  • 4: filed on 2023-01-05 by LINDMARK BERTIL
  • 4: filed on 2022-06-15 by MUNSHI AMIT
  • 4: filed on 2022-06-15 by SHAPIRO DAVID
  • 4: filed on 2022-06-15 by PRENER ANNE

    • Events (8k)

  • 8-K: filed on 2023-10-23:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-02:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2023-09-26:
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-15:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-15:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-03-10:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2023-01-06:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-31:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-29:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-17:
    Item 5.07: Submission of Matters to a Vote of Security Holders

    • Proposed Sales (Form 144)

  • 144: filed on 2023-10-02:
  • 144: filed on 2023-10-02:
  • 144: filed on 2023-10-02:
  • 144: filed on 2023-10-02:
  • 144: filed on 2023-08-30:
  • 144: filed on 2023-08-30:
  • 144: filed on 2023-08-30:
  • 144: filed on 2023-08-30:
  • 144/A: filed on 2023-08-21:
  • 144: filed on 2023-08-21:

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    ORBIMED ADVISORS LLC

    ORBIMED GENESIS GP LLC

    ORBIMED ISRAEL GP II, L.P.

    ORBIMED ADVISORS ISRAEL II LTD

    ORBIMED CAPITAL GP VII LLC

    • 10% Owner
    		 2,238,627 2023-08-15 7

    GOLDFISCHER CARL

    • Director
    		 0 2023-06-14 1

    SHAPIRO DAVID

    • Director
    		 0 2023-06-14 1

    KHUONG CHAU QUANG

    • Director
    		 0 2023-06-14 1

    MUNSHI AMIT

    • Director
    		 0 2023-06-14 1

    DALLAS JAYSON DONALD ALEXANDER

    • Director
    		 0 2023-06-14 1

    PRENER ANNE

    • Director
    		 0 2023-06-14 1

    FREVE JONATHAN CHIEF FINANCIAL OFFICER

    • Officer
    		 115,000 2023-01-04 1

    WINSLOW GARRETT GENERAL COUNSEL

    • Officer
    		 80,000 2023-01-04 1

    SCHAMBYE HANS T. CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 300,000 2023-01-04 1

    LINDMARK BERTIL CHIEF MEDICAL OFFICER

    • Officer
    		 115,000 2023-01-04 1

    PEDERSEN ANDERS CHIEF OPERATING OFFICER

    • Officer
    		 115,000 2023-01-04 1

    OESTREICH STEPHANIE CHIEF BUSINESS OFFICER

    • Officer
    		 80,000 2023-01-04 1

    CHRISTGAU STEPHAN

    • Director
    		 546,136 2020-11-02 0

    NOVO HOLDINGS A/S

    • 10% Owner
    		 2,497,791 2020-11-02 0

    MOLLER SOREN

    • Director
    		 0 2020-10-28 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    GALECTO INC GLTO 2023-12-05 20:45:04 UTC -2.4261 7.7461 1400000
    GALECTO INC GLTO 2023-12-05 20:15:04 UTC -2.4261 7.7461 1400000
    GALECTO INC GLTO 2023-12-05 19:45:04 UTC -2.4261 7.7461 1400000
    GALECTO INC GLTO 2023-12-05 19:15:04 UTC -2.4261 7.7461 1400000
    GALECTO INC GLTO 2023-12-05 18:45:04 UTC -2.4261 7.7461 1400000
    GALECTO INC GLTO 2023-12-05 18:15:03 UTC -2.4261 7.7461 1400000
    GALECTO INC GLTO 2023-12-05 17:45:04 UTC -2.4261 7.7461 1400000
    GALECTO INC GLTO 2023-12-05 17:15:04 UTC -2.4261 7.7461 1400000
    GALECTO INC GLTO 2023-12-05 16:45:04 UTC -2.4261 7.7461 1400000
    GALECTO INC GLTO 2023-12-05 16:15:04 UTC -2.4261 7.7461 1400000
    GALECTO INC GLTO 2023-12-05 15:45:04 UTC -2.4261 7.7461 1400000
    GALECTO INC GLTO 2023-12-05 15:15:05 UTC -2.4261 7.7461 1400000
    GALECTO INC GLTO 2023-12-05 14:45:03 UTC -2.4261 7.7461 1400000
    GALECTO INC GLTO 2023-12-05 14:15:04 UTC -2.4261 7.7461 400000
    GALECTO INC GLTO 2023-12-05 13:45:04 UTC -2.6875 8.0075 400000
    GALECTO INC GLTO 2023-12-05 13:15:04 UTC -2.6875 8.0075 400000
    GALECTO INC GLTO 2023-12-05 12:45:05 UTC -2.6875 8.0075 400000
    GALECTO INC GLTO 2023-12-04 22:15:04 UTC -2.6875 8.0075 1400000
    GALECTO INC GLTO 2023-12-04 21:45:03 UTC -2.6875 8.0075 1400000
    GALECTO INC GLTO 2023-12-04 21:15:03 UTC -2.6875 8.0075 1400000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments